Akio Yamakawa

Most-cited papers

1. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome

   K. Arima, A. Kinoshita, H. Mishima, N. Kanazawa +26 more

   2011Proceedings of the National Academy of Sciences of the United States of America326 citations Open access

   Semantic Scholar

   Save

2. Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-α in THP-1 Cells and Monocytes

   T. Ikeda, Emi Kumagai, S. Iwata, Akio Yamakawa

   2013PLoS ONE57 citations Open access

   Semantic Scholar

   Save

3. HTLV-I Tax induces and associates with Crk-associated substrate lymphocyte type (Cas-L)

   S. Iwata, A. Souta-Kuribara, Akio Yamakawa, Takahiro Sasaki +8 more

   2005Oncogene22 citations

   Semantic Scholar

   Save

4. Combination therapy targeting Raf-1 and MEK causes apoptosis of HCT116 colon cancer cells.

   Romesh R. Subramanian, Akio Yamakawa

   2012International Journal of Oncology14 citations Open access

   Semantic Scholar

   Save

5. Transforming growth factor-β-induced CUX1 isoforms are associated with fibrosis in systemic sclerosis lung fibroblasts

   T. Ikeda, M. Fragiadaki, X. Shi-wen, M. Ponticos +7 more

   2016Biochemistry and Biophysics Reports6 citations Open access

   Semantic Scholar

   Save

6. Preparation of Antibody against Antitumor β-Glucan in Grifola frondosa and Its Application

   M. Mizuno, Akio Yamakawa, K. Minato, S. Kawakami +3 more

   19994 citations Open access

   Semantic Scholar

   Save

7. Data on CUX1 isoforms in idiopathic pulmonary fibrosis lung and systemic sclerosis skin tissue sections

   T. Ikeda, M. Fragiadaki, X. Shi-wen, M. Ponticos +7 more

   2016Data in Brief1 citations Open access

   Semantic Scholar

   Save

8. [Drug discovery using modified-monoclonal antibody technologies].

   Akio Yamakawa, S. Iwata

   2012Nihon rinsho. Japanese journal of clinical medicine0 citations

   Semantic Scholar

   Save